ACT HEALTHY: A Combined Cognitive-Behavioral Depression and Medication Adherence Treatment for HIV-Infected Substance Users

被引:50
作者
Daughters, Stacey B. [1 ]
Magidson, Jessica F.
Schuster, Randi M.
Safren, Steven A. [2 ,3 ]
机构
[1] Univ Maryland, Dept Publ & Community Hlth, College Pk, MD 20742 USA
[2] Harvard Univ, Sch Med, Cambridge, MA 02138 USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; PSYCHIATRIC-DISORDERS; TREATMENT RETENTION; COCAINE DEPENDENCE; CANCER-PATIENTS; RISK BEHAVIORS; DRUG-ABUSE; VIRAL LOAD; THERAPY; ACTIVATION;
D O I
10.1016/j.cbpra.2009.12.003
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
The two most common comorbid conditions with HIV are substance use disorders and depression, and individuals with comorbid HIV, depression, and substance dependence face a more chronic and treatment-resistant course. As an example of how to adapt evidence-based approaches to a complex comorbid population, the current case study examined the integration of a combined depression and HIV medication adherence treatment. The resulting intervention, ACT HEALTHY, combines a brief behavioral activation approach specifically developed to treat depression in individuals receiving residential substance abuse treatment (LETS ACT; Daughters et al., 2008) with a brief cognitive-behavioral approach to improving HIV medication adherence (Life-Steps; Safren el al., 1999; Safren et al., 2009). The current case series demonstrates the use of ACT HEALTHY among 3 depressed HIV-positive, low-income African Americans entering residential substance abuse treatment.
引用
收藏
页码:309 / 321
页数:13
相关论文
共 58 条
[41]  
Moneyham L, 2000, Sch Inq Nurs Pract, V14, P9
[42]   Testing the effectiveness of cognitive-behavioral treatment for substance abuse in a community setting: Within treatment and posttreatment findings [J].
Morgenstern, J ;
Blanchard, KA ;
Morgan, TJ ;
Labouvie, E ;
Hayaki, J .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 2001, 69 (06) :1007-1017
[43]  
Myers H., 1999, CULT DIVERS ETHN MIN, V5, P249
[44]   Disgust, anxiety and fainting symptoms associated with blood-injection-injury fears: a structural model [J].
Olatunji, BO ;
Williams, NL ;
Sawchuk, CN ;
Lohr, JM .
JOURNAL OF ANXIETY DISORDERS, 2006, 20 (01) :23-41
[45]   Adherence to medication treatment: A qualitative study of facilitators and barriers among a diverse sample of HIV+ men and women in four US cities [J].
Remien, RH ;
Hirky, AE ;
Johnson, MO ;
Weinhardt, LS ;
Whittier, D ;
Le, GM .
AIDS AND BEHAVIOR, 2003, 7 (01) :61-72
[46]   Treatment of cocaine dependence and depression [J].
Rounsaville, BJ .
BIOLOGICAL PSYCHIATRY, 2004, 56 (10) :803-809
[47]   Two strategies to increase adherence to HIV antiretroviral medication: Life-steps and medication monitoring [J].
Safren, SA ;
Otto, MW ;
Worth, JL ;
Salomon, E ;
Johnson, W ;
Mayer, K ;
Boswell, S .
BEHAVIOUR RESEARCH AND THERAPY, 2001, 39 (10) :1151-1162
[48]  
Safren SA., 1999, COGN BEHAV NEUROL, V6, P332, DOI DOI 10.1016/S1077-7229(99)80052-2
[49]   A Randomized Controlled Trial of Cognitive Behavioral Therapy for Adherence and Depression (CBT-AD) in HIV-Infected Individuals [J].
Safren, Steven A. ;
O'Cleirigh, Conall ;
Tan, Judy Y. ;
Raminani, Sudha R. ;
Reilly, Laura C. ;
Otto, Michael W. ;
Mayer, Kenneth H. .
HEALTH PSYCHOLOGY, 2009, 28 (01) :1-10
[50]   Psychiatric and substance dependence comorbidities, sexually transmitted diseases, and risk behaviors among methamphetamine-dependent gay and bisexual men seeking outpatient drug abuse treatment [J].
Shoptaw, S ;
Peck, J ;
Reback, CJ ;
Rotheram-Fuller, E .
JOURNAL OF PSYCHOACTIVE DRUGS, 2003, :161-168